Wu J - Search Results

1

Prostate-specific IL-6 transgene autonomously induce prostate neoplasm through amplifying inflammation in the prostate and peri-prostatic adipose tissue.

Liu G, Zhang J, Frey L, Gang X, Wu K, Liu Q, Lilly M, Wu J. Liu G, et al. Among authors: wu k, wu j. J Hematol Oncol. 2017 Jan 11;10(1):14. doi: 10.1186/s13045-016-0386-7. J Hematol Oncol. 2017. PMID: 28077171 Free PMC article.

2

Interaction of IGF signaling and the androgen receptor in prostate cancer progression.

Wu JD, Haugk K, Woodke L, Nelson P, Coleman I, Plymate SR. Wu JD, et al. J Cell Biochem. 2006 Oct 1;99(2):392-401. doi: 10.1002/jcb.20929. J Cell Biochem. 2006. PMID: 16639715 Review.

3

The membrane type matrix metalloproteinase MMP14 mediates constitutive shedding of MHC class I chain-related molecule A independent of A disintegrin and metalloproteinases.

Liu G, Atteridge CL, Wang X, Lundgren AD, Wu JD. Liu G, et al. J Immunol. 2010 Apr 1;184(7):3346-50. doi: 10.4049/jimmunol.0903789. Epub 2010 Mar 5. J Immunol. 2010. PMID: 20208009 Free PMC article.

4

IL-6 promotes prostate tumorigenesis and progression through autocrine cross-activation of IGF-IR.

Rojas A, Liu G, Coleman I, Nelson PS, Zhang M, Dash R, Fisher PB, Plymate SR, Wu JD. Rojas A, et al. Among authors: wu jd. Oncogene. 2011 May 19;30(20):2345-55. doi: 10.1038/onc.2010.605. Epub 2011 Jan 24. Oncogene. 2011. PMID: 21258401 Free PMC article.

5

3D porous chitosan-alginate scaffolds: a new matrix for studying prostate cancer cell-lymphocyte interactions in vitro.

Florczyk SJ, Liu G, Kievit FM, Lewis AM, Wu JD, Zhang M. Florczyk SJ, et al. Among authors: wu jd. Adv Healthc Mater. 2012 Sep;1(5):590-9. doi: 10.1002/adhm.201100054. Epub 2012 Jul 6. Adv Healthc Mater. 2012. PMID: 23184794 Free PMC article.

6

Perturbation of NK cell peripheral homeostasis accelerates prostate carcinoma metastasis.

Liu G, Lu S, Wang X, Page ST, Higano CS, Plymate SR, Greenberg NM, Sun S, Li Z, Wu JD. Liu G, et al. J Clin Invest. 2013 Oct;123(10):4410-22. doi: 10.1172/JCI69369. Epub 2013 Sep 9. J Clin Invest. 2013. PMID: 24018560 Free PMC article.

7

NKG2D Ligands in Tumor Immunity: Two Sides of a Coin.

Zhang J, Basher F, Wu JD. Zhang J, et al. Among authors: wu jd. Front Immunol. 2015 Mar 4;6:97. doi: 10.3389/fimmu.2015.00097. eCollection 2015. Front Immunol. 2015. PMID: 25788898 Free PMC article. Review.

8

Soluble NKG2D ligand promotes MDSC expansion and skews macrophage to the alternatively activated phenotype.

Xiao G, Wang X, Sheng J, Lu S, Yu X, Wu JD. Xiao G, et al. Among authors: wu jd. J Hematol Oncol. 2015 Feb 20;8:13. doi: 10.1186/s13045-015-0110-z. J Hematol Oncol. 2015. PMID: 25887583 Free PMC article.

9

Nonblocking Monoclonal Antibody Targeting Soluble MIC Revamps Endogenous Innate and Adaptive Antitumor Responses and Eliminates Primary and Metastatic Tumors.

Lu S, Zhang J, Liu D, Li G, Staveley-O'Carroll KF, Li Z, Wu JD. Lu S, et al. Among authors: wu jd. Clin Cancer Res. 2015 Nov 1;21(21):4819-30. doi: 10.1158/1078-0432.CCR-15-0845. Epub 2015 Jun 23. Clin Cancer Res. 2015. PMID: 26106076 Free PMC article.

10

Antibody targeting tumor-derived soluble NKG2D ligand sMIC provides dual co-stimulation of CD8 T cells and enables sMIC⁺ tumors respond to PD1/PD-L1 blockade therapy.

Zhang J, Larrocha PS, Zhang B, Wainwright D, Dhar P, Wu JD. Zhang J, et al. Among authors: wu jd. J Immunother Cancer. 2019 Aug 26;7(1):223. doi: 10.1186/s40425-019-0693-y. J Immunother Cancer. 2019. PMID: 31446896 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

76,623 results

Search Page

Filters